Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析

◆英語タイトル:Adverum Biotechnologies Inc (ADVM) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15105
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-related macular degeneration and juvenile X-linked retinoschisis a retinal disease caused by mutations. The company provides its ocular biofactory gene therapy platform to develop product candidates for rare diseases in the field of ophthalmology. It has collaborations with academic institutions and pharmaceutical companies, among others. It also offers research and development, pre clinical services and manufacturing services. Adverum is headquartered in Menlo Park, California, the US.

Adverum Biotechnologies Inc Key Recent Developments

Jan 06,2019: Adverum Biotechnologies provides 2019 outlook
Dec 03,2018: Adverum Biotechnologies names Mike Fitzgerald as vice president, human resources
Nov 19,2018: Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration
Nov 08,2018: Adverum Biotechnologies reports third quarter 2018 financial results and provides corporate update
Nov 01,2018: Adverum Biotechnologies Provides Program Updates

This comprehensive SWOT profile of Adverum Biotechnologies Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Adverum Biotechnologies Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Adverum Biotechnologies Inc – Key Information
Adverum Biotechnologies Inc – Overview
Adverum Biotechnologies Inc – Key Employees
Adverum Biotechnologies Inc – Key Employee Biographies
Adverum Biotechnologies Inc – Key Operational Heads
Adverum Biotechnologies Inc – Major Products and Services
Adverum Biotechnologies Inc – History
Adverum Biotechnologies Inc – Company Statement
Adverum Biotechnologies Inc – Locations And Subsidiaries
Adverum Biotechnologies Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Adverum Biotechnologies Inc – Business Description
Adverum Biotechnologies Inc – Corporate Strategy
Adverum Biotechnologies Inc – SWOT Analysis
SWOT Analysis – Overview
Adverum Biotechnologies Inc – Strengths
Adverum Biotechnologies Inc – Weaknesses
Adverum Biotechnologies Inc – Opportunities
Adverum Biotechnologies Inc – Threats
Adverum Biotechnologies Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Adverum Biotechnologies Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Adverum Biotechnologies Inc, Key Information
Adverum Biotechnologies Inc, Key Ratios
Adverum Biotechnologies Inc, Share Data
Adverum Biotechnologies Inc, Major Products and Services
Adverum Biotechnologies Inc, History
Adverum Biotechnologies Inc, Key Employees
Adverum Biotechnologies Inc, Key Employee Biographies
Adverum Biotechnologies Inc, Key Operational Heads
Adverum Biotechnologies Inc, Other Locations
Adverum Biotechnologies Inc, Subsidiaries
Adverum Biotechnologies Inc, Key Manufacturing facilities
Adverum Biotechnologies Inc, Key Competitors
Adverum Biotechnologies Inc, SWOT Analysis
Adverum Biotechnologies Inc, Ratios based on current share price
Adverum Biotechnologies Inc, Annual Ratios
Adverum Biotechnologies Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Adverum Biotechnologies Inc, Performance Chart
Adverum Biotechnologies Inc, Ratio Charts

★海外企業調査レポート[Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trinity Industries, Inc.:企業の戦略・SWOT・財務情報
    Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Trinity Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • VWR Corp (VWR)-医療機器分野:企業M&A・提携分析
    Summary VWR Corp (VWR) is a medical equipment company that distributes laboratory products, and provides services and solutions. The company offers product such chemicals, reagents, consumables, durable products, scientific equipment and instruments. It offers products in the areas of research and d …
  • Benefitfocus Inc (BNFT):企業の財務・戦略的SWOT分析
    Summary Benefitfocus Inc (Benefitfocus) is a technology service provider that offers cloud- based software solutions. The company provides cloud-based benefits management platform for shopping, enrolling, managing and exchanging benefit information for employers, insurance carriers, brokers, and con …
  • Altius Minerals Corporation:企業のM&A・事業提携・投資動向
    Altius Minerals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Altius Minerals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Sumitomo Bakelite Co Ltd (4203):企業の戦略的SWOT分析
    Sumitomo Bakelite Co Ltd (4203) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Kadimastem Ltd (KDST):製薬・医療:M&Aディール及び事業提携情報
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie) is a chemical company that manufactures and markets high performance polymers and specialty chemicals. The company's products include bonding products, polyamides, damping systems, sealants, coating products, thermoplastic material, technical fibers, and te …
  • Aptiv Plc. (APTV):企業の財務・戦略的SWOT分析
    Aptiv Plc. (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ansaldo Thomassen BV:企業の戦略的SWOT分析
    Ansaldo Thomassen BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Takara Holdings Inc (2531):企業の財務・戦略的SWOT分析
    Takara Holdings Inc (2531) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Energy Resources of Australia Ltd. (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd. (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • ContextVision AB (COV):企業の財務・戦略的SWOT分析
    Summary ContextVision AB (ContextVision) is a medical technology company that specializes in image analysis and artificial intelligence software solutions. The company develops image enhancement software solutions for magnetic resonance imaging, digital pathology, ultrasound, X-ray, fluoroscopy, mam …
  • Caisse de depot et placement du Quebec:企業のM&A・事業提携・投資動向
    Caisse de depot et placement du Quebec - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Caisse de depot et placement du Quebec Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務情報
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AcelRx Pharmaceuticals Inc (ACRX):医療機器:M&Aディール及び事業提携情報
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-t …
  • BioClinica Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies, Inc., is a clinical trials services provider. The company’s cloud-based offerings comprise medical image management solutions; electronic data capture (EDC) solutions; clinical data management; clinical trial management systems …
  • Young’s Seafood Limited:企業の戦略・SWOT・財務情報
    Young's Seafood Limited - Strategy, SWOT and Corporate Finance Report Summary Young's Seafood Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Wakefern Food Corp.:企業の戦略的SWOT分析
    Wakefern Food Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • WPX Energy Inc (WPX):石油・ガス:M&Aディール及び事業提携情報
    Summary WPX Energy Inc (WPX Energy) is an oil and gas company that carries out drilling and exploration activities. The company exploits and develops unconventional properties. It produces natural gas, natural gas liquids and crude oil from non-conventional resources including tight-sands, shale for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆